Patents-Review.com
ClassID:

96779 ⎘

C07K14/045 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; DNA viruses; Herpetoviridae, e.g. pseudorabies virus; Varicella-zoster virus Cytomegalovirus

Recent Application in this class:
#1
20240383949
2024-11-21

MODIFIED CYTOMEGALOVIRUS PROTEINS AND STABILIZED COMPLEXES

 #2
20240100153
2024-03-28

HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE

 #3
20240058437
2024-02-22

IMMUNOGENIC PEPTIDE

 #4
20230405047
2023-12-21

Methods and compositions for eliminating engineered immune cells

 #5
20230173061
2023-06-08

HUMAN CYTOMEGALOVIRUS POLYEPITOPE VACCINE COMPOSITION

 #6
20230140549
2023-05-04

Expression system for expressing herpesvirus glycoprotein complexes

 #7
20220105178
2022-04-07

Ii vaccine adjuvant

 #8
20220088184
2022-03-24

Human cytomegalovirus GB polypeptide

 #9
20220064225
2022-03-03

Human cytomegalovirus comprising exogenous antigens

 #10
20210277067
2021-09-09

Modified cytomegalovirus proteins and stabilized complexes

 #11
20210107967
2021-04-15

Precision activation of HIV-specific CTLS to eliminate reactivated latent T cells

 #12
20200207873
2020-07-02

Antibodies and peptides to treat HCMV related diseases

 #13
20200155670
2020-05-21

Expression system for expressing herpesvirus glycoprotein complexes

 #14
20200102354
2020-04-02

Human cytomegalovirus comprising exogenous antigens

 #15
20190374636
2019-12-12

Ii vaccine adjuvant

 #16
20190270779
2019-09-05

Re-directed immunotherapy

 #17
20190099479
2019-04-04

Recombinant HCMV and RHCMV vectors and uses thereof

 #18
20180282378
2018-10-04

Human cytomegalovirus comprising exogenous antigens

 #19
20170267722
2017-09-21

Inhibitory peptides of viral infection

 #20
20160114027
2016-04-28

Recombinant HCMV and RHCMV vectors and uses thereof

 #21
20160016999
2016-01-21

Inhibitory peptides of viral infection

 #22
20150119318
2015-04-30

Peptide compositions and methods for inhibiting herpesvirus infection

 #23
20140186382
2014-07-03

Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection

 #24
20130164289
2013-06-27

HUMAN CYTOMEGALOVIRUS VACCINE

 #25
20130136768
2013-05-30

Recombinant HCMV and RHCMV vectors and uses thereof

 #26
20130045221
2013-02-21

T-cell receptor capable of recognising an antigen from cytomegalovirus

 #27
20130017217
2013-01-17

Codon-optimized polynucleotide-based vaccines against human infection

 #28
20130005648
2013-01-03

Peptide compositions and methods for inhibiting herpesvirus infection

 #29
20120237921
2012-09-20

Full genome DNA of human cytomegalovirus strain JHC isolated from Korean patient and open reading frames thereof

 #30
20110177124
2011-07-21

Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection

 #31
20080085870
2008-04-10

Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection